Digestive and Liver Disease

Article	Citations
Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO	80
Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration	75
Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial	70
Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis	68
Diagnosing chronic atrophic gastritis by gastroscopy using artificial intelligence	67
COVID 19 and liver: An A–Z literature review	61
From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies	61
Systemic inflammation as fuel for acute liver injury in COVID-19	61
Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis	58
COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine	54
Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver	51
Foreign body and caustic ingestions in children: A clinical practice guideline	48
Antidiabetic drugs and non-alcoholic fatty liver disease: A systematic review, meta-analysis and evidence map	48
Impact of the COVID-19 pandemic on Gastroenterology Divisions in Italy: A national survey	48
Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review	46
Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD	46
Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases	44
Intestinal ischemia in the COVID-19 era	44
Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey	40
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging	40
COVID-19 and intestinal inflammation: Role of fecal calprotectin	40
Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population	39
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease	38
Optimizing systemic therapy for advanced hepatocellular carcinoma: the key role of liver function	38
Furin inhibits epithelial cell injury and alleviates experimental colitis by activating the Nrf2-Gpx4 signaling pathway	38

Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part II: Treatment	36
COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)	34
COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data	33
Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection	32
Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis	32
Gastritis: The clinico-pathological spectrum	31
Analysis of patients attitude to undergo urgent endoscopic procedures during COVID-19 outbreak in Italy	29
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED)	29
Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis	28
COVID-19 in IBD: The experience of a single tertiary IBD center	28
Long non-coding RNA OIP5-AS1 promotes the growth of gastric cancer through the miR-367-3p/HMGA2 axis	27
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis	27
Update on gastroenteropancreatic neuroendocrine tumors	27
A SIGE-SINGEM-AIGO technical review on the clinical use of esophageal reflux monitoring	27
Endoscopic ultrasound-guided gastro-enteric anastomosis: A systematic review and meta-analysis	27
Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19	27
Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey	27
Endoscopic ultrasound-guided vs ERCP-guided biliary drainage for malignant biliary obstruction: A up-to-date meta-analysis and systematic review	25
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila	24
Circ-SMARCA5 suppresses colorectal cancer progression via downregulating miR-39-3p and upregulating ARID4B	23
Italian guidelines for the management of irritable bowel syndrome	23
The impact of reader fatigue on the accuracy of capsule endoscopy interpretation	23
Latest insights into the hot question of proton pump inhibitor safety – a narrative review	23
Splanchnic vein thrombosis in COVID-19: A review of literature	22
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey	22
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population	22
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology	22
A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial	22
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients	21
Seronegative autoimmune atrophic gastritis is more common in elderly patients	21
Systematic Review: esophageal motility patterns in patients with eosinophilic esophagitis	20
High rate of re-bleeding after application of Hemospray for upper and lower gastrointestinal bleeds	20
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population	20
Covid-19 and alcohol associated liver disease	20
The low FODMAP diet for IBS; A multicentre UK study assessing long term follow up	20
Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation	20
Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program	20
Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study	20
MAFLD vs NAFLD: Where are we?	19
Guidelines of the Italian societies of gastroenterology on the diagnosis and management of coeliac disease and dermatitis herpetiformis	19
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group	19
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis	18
Returning to digestive endoscopy normality will be slow and must include novelty and telemedicine	18
“Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial”	18
Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma	18
Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs	18
A negative fallout of COVID-19 lockdown in Italy: Life-threatening delay in the diagnosis of celiac disease	18
Trust in telemedicine from IBD outpatients during the COVID-19 pandemic	18
IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway	18
Leptin induces NAFLD progression through infiltrated CD8+ T lymphocytes mediating pyroptotic-like cell death of hepatocytes and macrophages	18

Endoscopy during the Covid-19 outbreak: experience and recommendations from a single center in a high-incidence scenario	18
Efficacy and safety of albumin infusion for overt hepatic encephalopathy: A systematic review and meta-analysis	18
Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms	17
Prevalence and detection rate of celiac disease in Italy: Results of a SIGENP multicenter screening in school-age children	17
PD-L1 and HER2 expression in gastric adenocarcinoma and their prognostic significance	17
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis	17
Painless chronic pancreatitis	17
Esophageal reflux hypersensitivity: Non-GERD or still GERD?	17
Differential diagnosis of pancreatic cysts: A prospective study on the role of intra-cystic glucose concentration	17
Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk region	17
Time course and risk factors of evolution from potential to overt autoimmune gastritis	17
Ultrasound-guided stellate ganglion block alleviates stress responses and promotes recovery of gastrointestinal function in patients	17
Vaccinations and inflammatory bowel disease – a systematic review	17
Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre study	16
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study	16
Ustekinumab in bio-naïve and bio-failure Crohn's disease patients: Results from a « real-life » monocentric cohort.	16
NAFLD, MAFLD and DAFLD	16
LncRNA miR503HG inhibits epithelial-mesenchymal transition and angiogenesis in hepatocellular carcinoma by enhancing PDCD4 via regulation of miR-15b	16
Clinical management and patient outcomes of acute lower gastrointestinal bleeding. A multicenter, prospective, cohort study	16
Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: A systematic review and meta-analysis	16
Clinical guidelines for the management of inflammatory bowel disease: Update of a French national consensus	16
Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group	16
Treatment of primary sclerosing cholangitis	16
Long term results of liver transplantation for alpha-1 antitrypsin deficiency	16
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease	16
Acute splanchnic vein thrombosis in patients with COVID-19: A systematic review	16
Difficult biliary cannulation in patients with distal malignant biliary obstruction: An underestimated problem?	16
Female reproductive health and inflammatory bowel disease: A practice-based review	16
Treatment guidelines of metastatic colorectal cancer in older patients from the French Society of Geriatric Oncology (SoFOG)	16
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group	15
Redesign of a GI endoscopy unit during the COVID-19 emergency: A practical model	15
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis	15
Onset of ulcerative colitis during SARS-CoV-2 infection	15
Intelligent detection endoscopic assistant: An artificial intelligence-based system for monitoring blind spots during esophagogastroduodenoscopy in real-time	15
A deep learning method to assist with chronic atrophic gastritis diagnosis using white light images	15
The importance of sarcopenia as a prognostic predictor of the clinical course in acute severe ulcerative colitis patients	15
Hepatitis B reactivation and immune check point inhibitors	15
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis	15
TGM3 promotes epithelial–mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection	15
Current treatment options of refractory ascites in liver cirrhosis – A systematic review and meta-analysis	15
Clinical application of carbon nanoparticles in lymphatic mapping during colorectal cancer surgeries: A systematic review and meta-analysis	14
Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivators	14
Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure	14
The application of artificial intelligence in hepatology: A systematic review	14
Sustainability in gastroenterology and digestive endoscopy: Position Paper from the Italian Association of Hospital Gastroenterologists and Digestive Endoscopists (AIGO)	14
The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab	14
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis	14
FAPI PET/CT research progress in digestive system tumours	14
Colectomy rates in ulcerative colitis: A systematic review and meta-analysis	14
Assessment of biopsy proven liver fibrosis by two-dimensional shear wave elastography in patients with primary biliary cholangitis	14
Genetic and non-genetic risk factors for early-onset pancreatic cancer	14
Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry	14
Liver fibrosis improvement in chronic hepatitis C after direct acting-antivirals is accompanied by reduced profibrogenic biomarkers–a role for MMP-9/TIMP-1	14
Tumor-derived extracellular vesicles containing long noncoding RNA PART1 exert oncogenic effect in hepatocellular carcinoma by polarizing macrophages into M2	14
Management of patients with complex perianal fistulas in Crohn's disease: Optimal patient flow in the Italian clinical reality	14
Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort	14
TRPM7 is overexpressed in human IBD-related and sporadic colorectal cancer and correlates with tumor grade	14
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group	14
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel	13
COVID-19-related thrombotic microangiopathy in a cirrhotic patient	13
Will the COVID-19 pandemic affect HCV disease burden?	13
Italian association for the study of the liver position statement on SARS-CoV2 vaccination	13
Serum bile acids in cystic fibrosis patients – glycodeoxycholic acid as a potential marker of liver disease	13
Effectiveness and safety of NER1006 versus standard bowel preparations: A meta-analysis of randomized phase-3 clinical trials	13
Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease	13
ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study	13
Mitochondrial DNA from hepatocytes induces upregulation of interleukin-33 expression of macrophages in nonalcoholic steatohepatitis	13
Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's disease	13
Comparison of 18FDG-PET/CT and conventional follow-up methods in colorectal cancer: A randomised prospective study	12
Vaccinations in patients with inflammatory bowel disease	12
Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus	12
Effect of poorly absorbable antibiotics on hepatic venous pressure gradient in cirrhosis: A systematic review and meta-analysis	12
Faecal bile acids and colonic bile acid membrane receptor correlate with symptom severity of diarrhoea-predominant irritable bowel syndrome: A pilot study	12
Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial	12
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian S	12
ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed	12
Exosomal microRNA-25 released from cancer cells targets SIK1 to promote hepatocellular carcinoma tumorigenesis	12
Higher rate of en bloc resection with underwater than conventional endoscopic mucosal resection: A meta-analysis	12
Clinical impact of videocapsule and double balloon enteroscopy on small bowel bleeding: Results from a large monocentric cohort in the last 19 years	12
Low frequency of COVID-19 in inflammatory bowel diseases	12

Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease: Impact on renal function	12
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study	12
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines	12
Clinical and gastro-duodenal histopathological features of enteropathy due to angiotensin II receptor blockers	12
High ulcerative colitis and Crohn's disease ratio in a population-based registry from Córdoba, Argentina	12
SARS-CoV-2 and gastrointestinal tract: The dark side of the pandemic	12
MRI features for differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A systematic review and meta-analysis	12
Splenic-hepatic elastography index is useful in differentiating between porto-sinusoidal vascular disease and cirrhosis in patients with portal hypertension	12
Post COVID-19 cholangiopathy – A deep dive	12
Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial	12
Hepatic epithelioid hemangioendothelioma: An international multicenter study	12
Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with β-blockers and ligation	12
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study	12
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease	12
HBx acts as an oncogene and promotes the invasion and metastasis of hepatocellular carcinoma both in vivo and vitro	11
Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFR	11
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank	11
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors	11
PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer	11
Magnetic resonance imaging assessment of body composition parameters in Crohn's disease	11
Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic	11
Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian Association for the Study of the Liver (AISF)	11
A retrospective study on efficacy of the ERAS protocol in patients undergoing surgery for Crohn disease: A propensity score analysis	11
Eosinophilic gastrointestinal disorders in children and adolescents: A single-center experience	11
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy	11
Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group	11
Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak	11
Systemic steroids have a role in treating esophageal strictures in pediatric eosinophilic esophagitis	11
Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts	11
Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry	11
Uncontrolled diabetes mellitus increases risk of infection in patients with advanced cirrhosis	11
Systematic assessment of environmental factors for gastroesophageal reflux disease: An umbrella review of systematic reviews and meta-analyses	11
The Baveno VII concept of cirrhosis recompensation	11
Inflammatory bowel diseases and the risk of adverse health outcomes: Umbrella review of meta-analyses of observational studies	11
Exposed endoscopic full-thickness resection without laparoscopic assistance for gastric submucosal tumors: A systematic review and pooled analysis	11
Systematic review and meta-analysis: Artificial intelligence for the diagnosis of gastric precancerous lesions and Helicobacter pylori infection	11
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation	11
Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study	11
B-cell activating factor (BAFF) expression is associated with Crohn's disease and can serve as a potential prognostic indicator of disease response to Infliximab treatment	11
Spontaneous portosystemic shunts in cirrhosis: Detection, implications, and clinical associations	11
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology	11
Long non-coding RNA HAND2-AS1 inhibits gastric cancer progression by suppressing TCEAL7 expression via targeting miR-769–5p	10
Clinical features and psychological impact of celiac disease at diagnosis	10
Medical therapy versus surgery in moderate-to-severe ulcerative colitis	10
The diagnostic value of exosomal miRNAs in human bile of malignant biliary obstructions	10
Early microscopic findings in preclinical inflammatory bowel disease	10
Trends in cirrhosis hospitalizations during the COVID-19 pandemic	10
Laryngeal signs and pH-multichannel intraluminal impedance in infants and children: The missing ring	10
Endoscopic snare papillectomy for adenoma of the ampulla of vater: Long-term results in 135 consecutive patients	10
Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry	10
The safety and efficacy evaluation of sodium-glucose co-transporter 2 inhibitors for patients with non-alcoholic fatty liver disease: An updated meta-analysis	10
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis	10
Complete response to the combination of sintilimab and IBI305 for a patient with HBV-associated hepatocellular carcinoma with multiple lung metastasis	10
WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability	10
Collagenous gastritis: Epidemiology and clinical associations	10
A systematic review and meta-analysis on the impact of pre-existing and new-onset atrial fibrillation on outcomes before and after liver transplantation	10
Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival	10
Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF)	10
Gastric microbiota composition in patients with corpus atrophic gastritis	10
Histological assessment of gastric pseudopyloric metaplasia: Intra- and inter-observer consistency	10
Relationship between duodenal microbiota composition, clinical features at diagnosis, and persistent symptoms in adult Coeliac disease	10
Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP	10
Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19	10
c-Myc affects hedgehog pathway via KCNQ1OT1/RAC1: A new mechanism for regulating HSC proliferation and epithelial-mesenchymal transition	9
Effectiveness of a screening program for HBV, HCV, and HIV infections in African migrants to Sicily	9
Double-headed small-bowel capsule endoscopy: Real-world experience from a multi-centre British study	9
Gastrointestinal endoscopy in children and adults: How do they differ?	9
The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis	9
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin	9
Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials	9
Long non-coding RNA CASC9 promotes the progression and development of gastric cancer via regulating miR-370/EGFR axis	9
HOTAIR modulates hepatocellular carcinoma progression by activating FUT8/core-fucosylated Hsp90/MUC1/STAT3 feedback loop via JAK1/STAT3 cascade	9
Safety in digestive endoscopy procedures in the covid era recommendations in progres of the italian society of digestive endoscopy	9
Kidney function monitoring to prevent 5-aminosalicylic acid nephrotoxicity: What the gastroenterologist should know	9
MiR-21 regulates epithelial–mesenchymal transition in intestinal fibrosis of Crohn's disease by targeting PTEN/mTOR	9
Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial	9
Genome-wide DNA methylation profiling in nonalcoholic fatty liver reveals predictive aberrant methylation in PRKCE and SEC14L3 promoters	9
E2F5 promotes proliferation and invasion of gastric cancer through directly upregulating UBE2T transcription	9
What gastroenterologists should know about direct oral anticoagulants	9
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study	9
Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia	9
The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices	9
LncRNA ILF3-AS1 promotes cell migration, invasion and EMT process in hepatocellular carcinoma via the miR-628–5p/MEIS2 axis to activate the Notch pathway	9
Older patients with eosinophilic esophagitis have high treatment response to topical steroids	9
The global, regional, and national burden of inflammatory bowel diseases, 1990–2019: A systematic analysis for the global burden of disease study 2019	9
IBDs and the pediatric age: Their peculiarities and the involvement of the microbiota	9
WHOLE-meal ancient wheat-based diet: Effect on metabolic parameters and microbiota	9
The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysis	9
Anti-SARS-CoV-2 immunoglobulin profile in patients with celiac disease living in a high incidence area	8
Pseudogene PLGLA exerts anti-tumor effects on hepatocellular carcinoma through modulating miR-324–3p/GLYATL1 axis	8
Children and Fecal SARS-CoV-2 shedding: Just the tip of the Iceberg of Italian COVID-19 outbreak?	8
Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis	8
Antitissue transglutaminase antibodies’ normalization after starting a gluten-free diet in a large population of celiac children-a real-life experience	8
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial	8
Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease	8